148 related articles for article (PubMed ID: 23033004)
1. Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601).
Komiyama K; Kobayashi K; Minezaki S; Kotajima F; Sutani A; Kasai T; Mori K; Hoshi E; Takayanagi N; Koyama S; Eguchi K; Nakayama M; Kikuchi K;
Br J Cancer; 2012 Oct; 107(9):1474-80. PubMed ID: 23033004
[TBL] [Abstract][Full Text] [Related]
2. Phase II Study of S-1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non-Small Cell Lung Cancer.
Chihara Y; Yoshimura A; Date K; Takemura Y; Tamiya N; Kohno Y; Imabayashi T; Takeuchi M; Kaneko Y; Yamada T; Ueda M; Arimoto T; Uchino J; Iwasaki Y; Takayama K
Oncologist; 2019 Aug; 24(8):1033-e617. PubMed ID: 31040252
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer.
Oki Y; Hirose T; Yamaoka T; Kusumoto S; Shirai T; Sugiyama T; Okuda K; Nakashima M; Murata Y; Ohmori T; Adachi M
Cancer Chemother Pharmacol; 2011 Apr; 67(4):791-7. PubMed ID: 20556612
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II study of docetaxel and S-1, an oral fluorinated pyrimidine, for untreated advanced non-small cell lung cancer.
Takiguchi Y; Tada Y; Gemma A; Kudoh S; Hino M; Yoshimori K; Yoshimura A; Nagao K; Niitani H
Lung Cancer; 2010 Jun; 68(3):409-14. PubMed ID: 19740565
[TBL] [Abstract][Full Text] [Related]
5. A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial.
Kubota K; Sakai H; Katakami N; Nishio M; Inoue A; Okamoto H; Isobe H; Kunitoh H; Takiguchi Y; Kobayashi K; Nakamura Y; Ohmatsu H; Sugawara S; Minato K; Fukuda M; Yokoyama A; Takeuchi M; Michimae H; Gemma A; Kudoh S;
Ann Oncol; 2015 Jul; 26(7):1401-8. PubMed ID: 25908605
[TBL] [Abstract][Full Text] [Related]
6. A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer.
Chikamori K; Kishino D; Takigawa N; Hotta K; Nogami N; Kamei H; Kuyama S; Gemba K; Takemoto M; Kanazawa S; Ueoka H; Segawa Y; Takata S; Tabata M; Kiura K; Tanimoto M;
Lung Cancer; 2009 Jul; 65(1):74-9. PubMed ID: 19056143
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II study of docetaxel and S-1 in patients with previously treated non-small cell lung cancer.
Atagi S; Kawahara M; Kusunoki Y; Takada M; Kawaguchi T; Okishio K; Kubo A; Uehira K; Yumine K; Tomizawa Y; Saito R; Fukai S; Komatsu H
J Thorac Oncol; 2008 Sep; 3(9):1012-7. PubMed ID: 18758304
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer.
Yoshida K; Ninomiya M; Takakura N; Hirabayashi N; Takiyama W; Sato Y; Todo S; Terashima M; Gotoh M; Sakamoto J; Nishiyama M
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3402-7. PubMed ID: 16740764
[TBL] [Abstract][Full Text] [Related]
9. [A combination study of S-1 and docetaxel in patients with head and neck cancer].
Ito H; Yoshida T; Tokashiki R; Shimizu A; Hiramatsu H; Tsukahara K; Funato N
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():160-2. PubMed ID: 16897994
[TBL] [Abstract][Full Text] [Related]
10. A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110).
Nishino K; Imamura F; Kumagai T; Katakami N; Hata A; Okuda C; Urata Y; Hattori Y; Tachihara M; Yokota S; Nishimura T; Kaneda T; Satouchi M; Morita S; Negoro S
Lung Cancer; 2015 Aug; 89(2):146-53. PubMed ID: 26093793
[TBL] [Abstract][Full Text] [Related]
11. Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study.
Frasci G; Comella P; Thomas R; Di Bonito M; Lapenta L; Capasso I; Botti G; Vallone P; De Rosa V; D'Aiuto G; Comella G
Cancer Chemother Pharmacol; 2004 Jan; 53(1):25-32. PubMed ID: 14513281
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of carboplatin combined with biweekly docetaxel for advanced non-small cell lung cancer.
Ishimoto O; Sugawara S; Inoue A; Ishida T; Munakata M; Koinumaru S; Hasegawa Y; Suzuki T; Miki H; Saijo Y; Nukiwa T
J Thorac Oncol; 2006 Nov; 1(9):979-83. PubMed ID: 17409982
[TBL] [Abstract][Full Text] [Related]
13. Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809.
Niho S; Ikeda N; Michimae H; Suzuki K; Sakai H; Kaburagi T; Minato K; Kato T; Okamoto H; Seto T; Hosomi Y; Shimizu K; Oshita F; Kunitoh H; Tsuboi M; Takeuchi M; Watanabe K
Br J Cancer; 2013 Aug; 109(3):545-51. PubMed ID: 23868010
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer).
Nokihara H; Lu S; Mok TSK; Nakagawa K; Yamamoto N; Shi YK; Zhang L; Soo RA; Yang JC; Sugawara S; Nishio M; Takahashi T; Goto K; Chang J; Maemondo M; Ichinose Y; Cheng Y; Lim WT; Morita S; Tamura T
Ann Oncol; 2017 Nov; 28(11):2698-2706. PubMed ID: 29045553
[TBL] [Abstract][Full Text] [Related]
15. [Combination therapy with S-1 plus docetaxel (DOC) for previously treated patients with non-small cell lung cancer].
Atagi S
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():197-201. PubMed ID: 16898002
[TBL] [Abstract][Full Text] [Related]
16. A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy: results of Okayama Lung Cancer Study Group (OLCSG) Trial 0503.
Segawa Y; Kiura K; Hotta K; Takigawa N; Tabata M; Matsuo K; Yoshioka H; Hayashi H; Kawai H; Aoe K; Maeda T; Ueoka H; Tanimoto M
J Thorac Oncol; 2010 Sep; 5(9):1430-4. PubMed ID: 20651615
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer.
Yoshida K; Hirabayashi N; Takiyama W; Ninomiya M; Takakura N; Sakamoto J; Nishiyama M; Toge T
Anticancer Res; 2004; 24(3b):1843-51. PubMed ID: 15274365
[TBL] [Abstract][Full Text] [Related]
18. [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].
Li JL; Zhang XR; Liu JW; Chen ZY; Lin YC; Wang YD; Chen Q; Nan KJ; Song SP; Han FC; Zhu YZ; Li LY; Zheng YH; Chu DT
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):309-12. PubMed ID: 16875636
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer.
Goya H; Kuraishi H; Koyama S; Ichiyama T; Yoshiike F; Hirai K; Agatsuma T; Tateishi K; Kanda S; Yamamoto H; Kubo K; Koizumi T
Cancer Chemother Pharmacol; 2012 Nov; 70(5):691-7. PubMed ID: 22941346
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma.
Park SR; Kim HK; Kim CG; Choi IJ; Lee JS; Lee JH; Ryu KW; Kim YW; Bae JM; Kim NK
Br J Cancer; 2008 Apr; 98(8):1305-11. PubMed ID: 18362939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
